Neovasc (NVCN) Stock Price, News & Analysis

Company Overview

Neovasc, Inc. engages in the development, manufacture and marketing of medical devices. It focuses on Neovast Tiara and Neovasc Reducer products. The company was founded on November 2, 2000 and is headquartered in Richmond, Canada.

Key Stats

• Today's Range: N/A
• 50-Day Range: $29.03 to $30.03
• 52-Week Range: N/A
• Volume: 1 shs
• Average Volume: 56,993 shs
• Market Capitalization: $82.28 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

NVCN Stock Analysis - Frequently Asked Questions

How were Neovasc's earnings last quarter?

Neovasc Inc. (NASDAQ:NVCN) issued its quarterly earnings data on Tuesday, November, 9th. The medical equipment provider reported ($2.75) EPS for the quarter, missing analysts' consensus estimates of ($2.25) by $0.50. The medical equipment provider earned $0.70 million during the quarter, compared to the consensus estimate of $1.20 million. Neovasc had a negative trailing twelve-month return on equity of 127.25% and a negative net margin of 1,082.92%.

When did Neovasc's stock split?

Shares of Neovasc reverse split on Friday, April 29th 2022. The 1-25 reverse split was announced on Friday, April 29th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, April 29th 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

What other stocks do shareholders of Neovasc own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Neovasc investors own include Biopharmx (BPMX), Allstate (ALL), NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Micron Technology (MU) and Canopy Growth (CGC).

Company Calendar

• Last Earnings: 11/09/2021
• Today: 4/05/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: N/A
• Current Symbol: NASDAQ:NVCN
• CIK: 1399708
• Web: www.neovasc.com
• Phone: (604) 270-4344
• Fax: 604-270-4384
• Employees: 49
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($15.08)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-41,200,000.00
• Net Margins: -1,082.92%
• Pretax Margin: -1,082.26%
• Return on Equity: -127.25%
• Return on Assets: -80.31%

Debt

• Debt-to-Equity Ratio: 0.80
• Current Ratio: 2.96
• Quick Ratio: 2.85

Sales & Book Value

• Annual Sales: $3.81 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $5.77 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 2,740,000
• Free Float: N/A
• Market Cap: $82.28 million
• Optionable: Not Optionable
• Beta: 1.70